A Study of EXG102-031 in Participants With wAMD
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 9, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 9, 2024Recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:May 17, 2022Completed
Condition(s):Age Related Macular Degeneration (AMD)Last Updated:March 22, 2024Recruiting
Condition(s):Wet Age-related Macular DegenerationLast Updated:June 9, 2023Completed
Condition(s):Wet Macular DegenerationLast Updated:August 22, 2017Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:November 4, 2020Completed
Condition(s):Age-Related Macular DegenerationLast Updated:January 23, 2018Completed
Condition(s):Neovascular Age-Related Macular Degeneration (nAMD)Last Updated:May 22, 2023Recruiting
Condition(s):Age Related Macular DegenerationLast Updated:August 11, 2015Unknown status
Condition(s):Age-related Macular DegenerationLast Updated:September 27, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.